One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You …
Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »
One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS …
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
I recently did a Q&A interview with NeoStem CEO Dr. Robin Smith. I posted Part 1 of that interview a few days ago here. Now we have part two focused on VSEL, ES cells, and iPS cells. PK: I frequently have readers of my blog ask questions about VSEL. They seem puzzled and unsure of …
Interview with NeoStem CEO Robin Smith Part 2: VSEL, ES cells, and iPS cells Read More »
Human cloning is an important issue at both scientific and societal levels. Earlier I included a guest post from bioethicist, Arthur Caplan, on human cloning. Today I am posting a short Q&A with Nobel Laureate John Gurdon. I asked Gurdon three specific questions and below each I have listed his answer. My sense is that …
Nobel Laureate John Gurdon not a fan of idea of human cloning Read More »
Do you have a question about stem cells? Post it in the comment sections of this blog post and I’ll do my best to answer it. If I don’t know, I’ll look into it. Update: in 2020 I started a patient Q&A series that you can read here. The best comments/questions may end up as …
Got questions about stem cells? I’ll answer them. Read More »
Dr. Kevin D’Amour, Director of Stem Cell Research at Viacyte, gave an excellent, extremely interesting talk Friday morning: Developing an Encapsulated Stem Cell Therapy for Diabetes. In the talk, Dr. D’Amour gave a very detailed description of their products Pro-Islet and Encaptra. Together these products form an encapsulated beta-cell product that is in pre-clinical development …